When your veterinarian suspects a genetic cause for your dog’s otherwise unexplainable symptoms, MoxxiTech is here to help.
RALLEE® Certified Canine Diagnostic Panel 1 includes genetic testing for diseases with symptoms involving drug metabolism, nervous system, hearing, and vision that may be difficult to accurately diagnose clinically due to rarity or due to broad symptoms that are common to multiple diseases. Understanding the specific genetic cause for your dog’s symptoms allows your veterinarian to identify the best treatment possible, potentially including enrollment in experimental therapies.
Learn more about genetic testing Order a Sample Collection Kit Veterinarians: Order NowCanine Diagnostic Panel 1 Genes and Conditions
Number of Alleles Tested: 174 |
|
Condition |
Gene(s) |
AC-3933 Poor Metabolizer 1 |
CYP1A2 |
Achromatopsia 1-4 |
CNGA3, CNGB3 |
Acral Mutilation Syndrome |
GDNF |
Alexander Disease |
GFAP |
Beta Mannosidosis 1, 2 |
MANBA |
Bilateral Deafness and Vestibular Dysfunction |
MYO7A |
Cerebellar Ataxia 1,2 |
RAB24, KCNIP4 |
Cerebellar Cortical Degeneration |
SNX14 |
Cerebellar Hypoplasia |
VLDLR |
Collie Eye Anomaly |
NHEJ1 |
Cone Rod Dystrophy, Age of Onset Modifier |
MAP9 |
Cone-Rod Dystrophy 1-4 |
NPHP4, IQCB1, RPGRIP1 |
Congenital Eye Malformations |
SIX6 |
Congenital Myasthenic Syndrome 1-5 |
CHAT, CHRNE, COLQ |
Copper Toxicosis |
COMMD1 |
Deafness, Unilateral and Vestibular Dysfunction |
PTPRQ |
Degenerative Myelopathy |
SOD1 |
Demyelinating Peripheral Neuropathy |
SBF2 |
Dermoid Sinus |
FGF3 |
Early Onset Cataracts 1, 2 |
HSF4 |
Early Retinal Degeneration |
STK38L |
Epileptic Drug Resistance |
ABCB1 |
Episodic Falling Syndrome |
BCAN |
Fetal Onset Neuroaxonal Dystrophy |
MFN2 |
Fucosidosis Alpha |
FUCA1 |
Gangliosidosis 1-3 |
GLB1 |
Generalized Myoclonic Epilepsy |
DIRAS1 |
Generalized Progressive Retinal Atrophy 1, 2 |
ADAM9, CCDC66 |
Globoid Cell Leukodystrophy 1, 2 |
GALC |
GM2 Gangliosidosis Type I |
HEXA |
GM2 Gangliosidosis Type II 1, 2 |
HEXB |
Hepatic Copper Toxicosis |
ATP7B |
Hyperekplexia 1, 2 |
SLC6A5 |
Hypomyelination of Central Nervous System |
FNIP2 |
Hypophosphatasia |
ALPL |
Ivermectin Sensitivity 1, 2 |
ABCB1 |
L-2-Hydroxyglutaric Aciduria 1, 2 |
L2HGDH |
Lagotto Storage Disease |
ATG4D |
Laryngeal Paralysis Risk Factor |
RAPGEF6 |
Leber Congenital Amaurosis |
RPE65 |
Leukodystrophy 1, 2 |
CYTB, TSEN54 |
Leukoencephalopathy 1, 2 |
NAPEPLD |
Macular Corneal Dystrophy |
LOC489707 |
Merle/Cryptic Merle |
PMEL |
Micropthalmia |
RBP4 |
Mucopolysaccharidosis Type I |
IDUA |
Mucopolysaccharidosis Type IIIA 1, 2 |
SGSH |
Mucopolysaccharidosis Type IIIB 1, 2 |
NAGLU |
Multifocal Retinopathy I 1, 2 |
BEST1 |
Multifocal Retinopathy II |
BEST1 |
Multifocal Retinopathy III 1, 2 |
BEST1 |
Myoclonus Epilepsy of Lafora |
NHLRC1 |
Myotubular Myopathy 1, 2 |
MTM1 |
Narcolepsy 1-3 |
HCRTR2 |
Necrotising Encephalopathy |
SLC19A3 |
Neonatal Cerebellar Ataxia |
GRM1 |
Neonatal Encephalopathy With Seizures |
ATF2 |
Neuroaxonal Dystrophy 1-3 |
PLA2G6, TECPR2, VPS11 |
Neuronal Ceroid Lipofuscinosis 1 |
PPT1 |
Neuronal Ceroid Lipofuscinosis 2 |
TPP1 |
Neuronal Ceroid Lipofuscinosis 3 |
PPT1 |
Neuronal Ceroid Lipofuscinosis 4A 1 |
ARSG |
Neuronal Ceroid Lipofuscinosis 5 1, 2 |
CLN5 |
Neuronal Ceroid Lipofuscinosis 6 |
CLN6 |
Neuronal Ceroid Lipofuscinosis 7 |
MFSD8 |
Neuronal Ceroid Lipofuscinosis 8 1-4 |
CLN8 |
Neuronal Ceroid Lipofuscinosis 10 |
CTSD |
Neuronal Ceroid Lipofuscinosis 12 1, 2 |
ATP13A2 |
Oculocutaneous Albinism |
OCA2 |
Oculocutaneous Albinism Type IV 1-3 |
SLC45A2 |
Oculoskeletal Dysplasia I 1, 2 |
COL9A3 |
Oculoskeletal Dysplasia II |
COL9A2 |
Osteochondromatosis |
EXT2 |
Paroxysmal Dyskinesia |
PIGN |
Periodic Fever Syndrome |
MTBP |
Photoreceptor Dysplasia |
PPT1 |
Polyneuropathy 1-6 |
NDRG1, RAB3GAP1, ARHGEF10, GJA9 |
Pompe Disease |
GAA |
Primary Glaucoma 1, 2 |
ADAMTS10 |
Primary Lens Luxation |
ADAMTS17 |
Primary Open Angle Glaucoma 1-3 |
ADAMTS17 |
Primary Open Angle Glaucoma and/or Primary Lens Luxation |
ADAMTS17 |
Progressive Early Onset Cerebellar Ataxia |
SEL1L |
Progressive Retinal Atrophy 1-10 |
BBS4, HIVEP3, CNGA1, CNGB1, MERTK, NECAP1, SAG1, SLC4A3, TTC8, RHO |
Progressive Retinal Atrophy Type 2 |
C17H2orf71 |
Progressive Retinal Atrophy X-Linked Type 1, 1-3 |
RPGR |
Progressive Retinal Atrophy X-Linked Type 2 |
RPGR |
Progressive Rod-Cone Degeneration (PRCD-PRA) |
PRCD |
Protection Against Liver Copper Accumulation |
ATP7A |
Refractory Idiopathic Epilepsy |
ABCB1 |
Remitting Focal Epilepsy |
LGI2 |
Rod-Cone Dysplasia Type 1, 1-4 |
PDE6B |
Rod-Cone Dysplasia Type 3 |
PDE6A |
Selective Cobalamin Malabsorption 1-3 |
CUBN |
Sensory Ataxic Neuropathy |
tRNA-TYR |
Sensory Neuropathy |
FAM134B |
Spinal Dyraphism |
NKX2-8 |
Spinocerebellar Ataxia 1-7 |
SCN8A, KCNJ10, SPTBN2, CAPN1, ITPR1 |
Spongy Degeneration with Cerebellar Ataxia 1, 2 |
ATP1B2 |
Stargardt Disease |
ABCA4 |
Tremor |
PLP |